Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Investing.com -- Illumina received a bullish rating upgrade from JPMorgan, which raised its recommendation to Overweight from Neutral and lifted its December 2026 price target to $185 from $125, citing growing confidence in the DNA sequencing company's ability to sustain strong growth despite increasing competition.

The brokerage said concerns that customers could migrate to rival sequencing platforms have eased after recent surveys and industry checks indicated that Illumina's large clinical customers remain highly committed to its ecosystem. JPMorgan highlighted significant switching costs, widespread adoption of Illumina's NovaSeq X platform, and expanding demand for genomic testing as key factors supporting future growth.

A survey of 62 research and clinical customers suggested spending on sequencing instruments and consumables is expected to accelerate through 2027 and 2028, with respondents also forecasting gains in Illumina's share of next-generation sequencing activity. Clinical customers, in particular, indicated strong expectations for increased testing volumes and equipment purchases.

JPMorgan said structural growth drivers in precision medicine, including therapy selection, minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED) testing, should support sustained demand for sequencing. The bank also pointed to rising sequencing intensity as laboratories adopt whole-genome sequencing, RNA sequencing and broader multiomics workflows.

While Roche's Axelios 1 platform remains a competitive threat, JPMorgan argued that concerns over workflow complexity, reusable flow-cell contamination risks and higher DNA input requirements could slow customer adoption. The bank expects Illumina's clinical consumables business to deliver low- to mid-teens growth over the coming years, helping the company achieve high-single-digit organic revenue growth from 2027 onward.

JPMorgan forecasts Illumina's revenue will rise to $4.58 billion in 2026 from $4.34 billion in 2025, with adjusted earnings per share increasing to $5.23 from $4.84. The bank expects the company to maintain a mid- to high-teens earnings growth profile through the end of the decade.

Related articles

Illumina upgraded to overweight at JPMorgan on clinical demand outlook

Wolfe Research outlines eight risks that could spark stock declines in 2026

This sector is 'poised for a big, beautiful year': Truist

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

The S&P 500 Index ($SPX) (SPY) today is down -0.61%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.88%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.80%.  June E-mini S&P futures (ESM26) are down -0.71%, and June E-mini Nasdaq futures (NQM26) are down -0.97%.

Stock indexes are sliding for a second day today, as chipmakers and AI-infrastructure stocks retreat.  Also, rising crude oil prices are weighing on airline stocks, and trucking companies are under pressure today after Amazon expanded its LTL freight offering to all destinations in the US, including third-party warehouses, distribution centers, and retail partners.Join 200K+ Subscribers: Find out why the midday Barchart Brief newsletter is a must-read for thousands daily.

Stocks found some support today after US May consumer prices came in as expected, easing inflation concerns.  Also, gains in crude oil prices today are lifting energy producers.

US May CPI rose +4.2% y/y, right on expectations and the fastest pace of increase in 3 years.  May core CPI rose +2.9% y/y, right on expectations, and the fastest pace of increase in 7 months.

US MBA mortgage applications rose +10.8% in the week ended June 5, with the purchase mortgage sub-index up +7.3% and the refinancing mortgage sub-index up +15.3%.  The average 30-year fixed rate mortgage rose +3 bp to 6.60% from 6.57% in the prior week.

WTI crude oil prices (CLN26) are up more than +1% today after the US and Iran exchanged strikes overnight.  The US said it had completed an operation that saw fighter jets strike Iranian air defenses, ground control stations, and radar sites near the Strait of Hormuz in retaliation for Iran shooting down a US Apache helicopter.  In response, Iran launched missiles at four US military targets and fired drones at the main US naval base in the Middle East, located in Bahrain, and struck Ali Al Salem air base in Kuwait.  Gains in crude prices accelerated today when President Trump said that Iran has taken too long to make a deal and that they will now have to “pay the price,” fueling concerns that the US may escalate military attacks on Iran.

The markets are discounting a 0% chance of a +25 bp rate hike at the next FOMC meeting on June 16-17.

Overseas stock markets are mixed today.  The Euro Stoxx 50 recovered from a 2.5-week low and is up +0.03%.  China's Shanghai Composite closed down -0.42%.  Japan's Nikkei Stock Average closed down -1.89%.

Interest Rates

September 10-year T-notes (ZNU6) today are down -1 tick, and the 10-year T-note yield is up +0.2 bp to 4.519%.  T-notes are under slight pressure today after a +1% jump in WTI crude oil, which has raised inflation expectations.  Supply pressures are also weighing on T-note prices as the Treasury will auction $39 billion of 10-year T-notes later today.  T-notes recovered from their worst levels after the US May CPI report rose as expected, easing inflation concerns.

European government bond yields are moving higher today.  The 10-year German Bund yield climbed to a 2.5-week high of 3.088% and is up +1.7 bp to 3.060%.  The 10-year UK gilt yield is up +1.7 bp to 4.920%.

Swaps are discounting a 100% chance of a +25 bp ECB rate hike at its next policy meeting on Thursday.

US Stock Movers

Chipmakers and AI-infrastructure stocks are leading the broader market lower today.  ON Semiconductor (ON) is down more than -5%, and Qualcomm (QCOM) is down more than -5% to lead losers in the Nasdaq 100.  Also, Western Digital (WDC) and Broadcom (AVGO) are down more than -4%, andAdvanced Micro Devices (AMD), NXP Semiconductors NV (NXPI), ARM Holdings Plc (ARM), and Microchip Technology (MCHP) are down more than -3%.  In addition,  Nvidia (NVDA), Marvell Technology (MRVL), and Micron Technology (MU) are down more than -2%.

Trucking companies are under pressure today after Amazon expanded its LTL freight offering to all destinations in the US, including third-party warehouses, distribution centers, and retail partners.  Old Dominion Freight Line (ODFL) is down more than -4%, and FedEx Freight Holding Co (FDXF), ArcBest (ARCB), and XPO Inc (XPO) are down more than -3%.  Also, Saia Inc (SAIA) is down more than -2%, and CH Robinson Worldwide (CHRW) and JB Hunt Transport Services (JBHT) are down more than -2%.

Airline stocks and cruise line operators are falling today, as WTI crude oil is up more than 1%, which is boosting fuel costs and dampening profitability prospects.  United Airlines Holdings (UAL), Alaska Air Group (ALK), and Carnival (CCL) are down more than -4%, and American Airlines Group (AAL), Delta Air Lines (DAL), Royal Caribbean Cruises (RCL), and Norwegian Cruise Line Holdings (NCLH) are down more than -3%.  Also, Southwest Airlines (LUV) is down more than -2%.

Energy producers and service providers are moving higher today, with WTI crude oil up more than +1%.  Devon Energy (DVN) is up more than +5%, and APA Corp (APA) is up more than +3%.  Also, ConocoPhillips (COP), Marathon Petroleum (MPC), Phillips 66 (PSX), and Chevron (CVX) are up more than +2%.  In addition, Diamondback Energy (FANG), Exxon Mobil (XOM), Halliburton (HAL), and Valero Energy (VLO) are up more than +1%.

Super Micro Computer (SMCI) is down more than -17% to lead losers in the S&P 500 after saying it plans $7 billion in equity and equity-linked financing transactions to fund component purchases.

Dianthus Therapeutics (DNTH) is down more than -13% after peer developer Sanofi halted a late-stage trial of an experimental therapy for a rare autoimmune disorder, citing efficacy concerns.

Summit Therapeutics (SMMT) is down more than -7% after announcing it had commenced an underwritten public offering of $500 million of shares of its common stock.

Cracker Barrel Old Country Store (CBRL) is up more than +27% after raising its full-year revenue forecast to $3.27 billion to $3.30 billion from a previous estimate of $3.24 billion to $3.27 billion, stronger than the consensus of $3.25 billion.

Casey’s General Stores (CASY) is up more than +14% to lead gainers in the S&P 500 after reporting Q4 revenue of $4.57 billion, above the consensus of $4.32 billion.

Illumina (ILMN) is up more than +3% after JPMorgan Chase upgraded the stock to overweight from neutral with a price target of $185.

Hinge Health (HNGE) is up more than +2% after raising its full-year revenue forecast to $818 million to $824 million from a previous estimate of $798 million to $804 million.

Earnings Reports(6/10/2026)

Chewy Inc (CHWY), Core & Main Inc (CNM), Oracle Corp (ORCL). On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More news from Barchart

Amid an Ugly Tech Selloff, Nvidia Director Mark Stevens Ditched 1 Million SharesOnly 1 Stock Is the Indispensable Backbone of the $1.8 Trillion Space Economy — and It’s Not SpaceXBillionaire Sam Altman Says OpenAI Was ‘Pretty Wrong’ About AI Jobs, But Goldman Sachs Warns AI is Still Wiping Out 11,000 Jobs Per MonthThe $500 Million Reason Redwire Stock Is Down Today

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

The S&P 500 Index ($SPX) (SPY) today is down -0.28%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.28%.  June E-mini S&P futures (ESM26) are down -0.25%, and June E-mini Nasdaq futures (NQM26) are down -0.22%.

Stock indexes are sliding today, led by weakness in technology stocks, as investors rotate out of the sector, weighing on the broader market. Also, trucking companies are under pressure today after Amazon expanded its LTL freight offering to all destinations in the US, including third-party warehouses, distribution centers, and retail partners.  However, stock indexes recovered from their worst levels after US May consumer prices came in as expected, easing inflation concerns.Join 200K+ Subscribers: Find out why the midday Barchart Brief newsletter is a must-read for thousands daily.

US May CPI rose +4.2% y/y, right on expectations and the fastest pace of increase in 3 years.  May core CPI rose +2.9% y/y, right on expectations, and the fastest pace of increase in 7 months.

US MBA mortgage applications rose +10.8% in the week ended June 5, with the purchase mortgage sub-index up +7.3% and the refinancing mortgage sub-index up +15.3%.  The average 30-year fixed rate mortgage rose +3 bp to 6.60% from 6.57% in the prior week.

WTI crude oil prices (CLN26) are up more than +1% today after the US and Iran exchanged strikes overnight.  The US said it had completed an operation that saw fighter jets strike Iranian air defenses, ground control stations, and radar sites near the Strait of Hormuz in retaliation for Iran shooting down a US Apache helicopter.  In response, Iran launched missiles at four US military targets and fired drones at the main US naval base in the Middle East, located in Bahrain, and struck Ali Al Salem air base in Kuwait.  Losses in crude prices accelerated today when President Trump said that Iran has taken too long to make a deal and that they will now have to “pay the price,” fueling concerns that the US may escalate military attacks on Iran.

The markets are discounting a 0% chance of a +25 bp rate hike at the next FOMC meeting on June 16-17.

Overseas stock markets are lower today.  The Euro Stoxx 50 fell to a 2.5-week low and is down -0.34%. China's Shanghai Composite closed down -0.42%.  Japan's Nikkei Stock Average closed down -1.89%.

Interest Rates

September 10-year T-notes (ZNU6) today are down -2 ticks, and the 10-year T-note yield is up +0.6 bp to 4.523%.  T-notes are under pressure today after a +1% jump in WTI crude oil, which has raised inflation expectations.  Supply pressures are also weighing on T-note prices as the Treasury will auction $39 billion of 10-year T-notes later today.

Today’s stock weakness has boosted some safe-haven demand for government debt securities and is limiting losses in T-notes.  Also, today’s as-expected US May CPI report limited the downside in T-notes.

European government bond yields are moving higher today.  The 10-year German Bund yield climbed to a 2.5-week high of 3.088% and is up +2.7 bp to 3.070%.  The 10-year UK gilt yield is up +2.1 bp to 4.924%.

Swaps are discounting a 100% chance of a +25 bp ECB rate hike at its next policy meeting on Thursday.

US Stock Movers

The weakness in chipmakers and AI-infrastructure stocks is leading the broader market lower today.  Western Digital (WDC) and Broadcom (AVGO) are down more than -4%, and Seagate Technology Holdings Plc (STX) is down more than -3%.  Also, Micron Technology (MU) is down more than -2%, and Nvidia (NVDA), Microchip Technology (MCHP), NXP Semiconductors NV (NXPI), and Qualcomm (QCOM) are down more than -1%.

Trucking companies are under pressure today after Amazon expanded its LTL freight offering to all destinations in the US, including third-party warehouses, distribution centers, and retail partners.  ArcBest (ARCB) is down more than -7%, and Old Dominion Freight Line (ODFL) is down more than -6% to lead losers in the Nasdaq 100.  Also, Saia Inc (SAIA) and XPO Inc (XPO) are down more than -5%.  In addition, FedEx Freight Holding Co (FDXF), CH Robinson Worldwide (CHRW), and JB Hunt Transport Services (JBHT) are down more than -2%.

Airline stocks and cruise line operators are falling today, as WTI crude oil is up more than 1%, which boosts fuel costs and dampens profitability prospects.  United Airlines Holdings (UAL) and Alaska Air Group (ALK) are down more than -3%, and American Airlines Group (AAL), Delta Air Lines (DAL), and Royal Caribbean Cruises (RCL) are down more than -2%.  Also, Southwest Airlines (LUV), Carnival (CCL), and Norwegian Cruise Line Holdings (NCLH) are down more than -1%.

Energy producers and service providers are moving higher today, with WTI crude oil up more than +1%.  Devon Energy (DVN) is up more than +4%, and APA Corp (APA) is up more than +3%.  Also, ConocoPhillips (COP) is up more than +2%, and Marathon Petroleum (MPC), Phillips 66 (PSX), Chevron (CVX), Halliburton (HAL), and Valero Energy (VLO) are up more than +1%.

Dianthus Therapeutics (DNTH) is down more than -13% after peer developer Sanofi halted a late-stage trial of an experimental therapy for a rare autoimmune disorder, citing efficacy concerns.

Super Micro Computer (SMCI) is down more than -12% to lead losers in the S&P 500 after saying it plans $7 billion in equity and equity-linked financing transactions to fund component purchases.

Summit Therapeutics (SMMT) is down more than -3% after announcing it had commenced an underwritten public offering of $500 million of shares of its common stock.

Cracker Barrel Old Country Store (CBRL) is up more than +31% after raising its full-year revenue forecast to $3.27 billion to $3.30 billion from a previous estimate of $3.24 billion to $3.27 billion, stronger than the consensus of $3.25 billion.

Casey’s General Stores (CASY) is up more than +14% to lead gainers in the S&P 500 after reporting Q4 revenue of $4.57 billion, above the consensus of $4.32 billion.

Illumina (ILMN) is up more than +2% after JPMorgan Chase upgraded the stock to overweight from neutral with a price target of $185.

Hinge Health (HNGE) is up more than +2% after raising its full-year revenue forecast to $818 million to $824 million from a previous estimate of $798 million to $804 million.

Earnings Reports(6/10/2026)

Chewy Inc (CHWY), Core & Main Inc (CNM), Oracle Corp (ORCL). On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More news from Barchart

DraftKings Stock Soars as Predictions Volume Explodes. DKNG’s Next Growth Engine Might Just Be Getting Started.Intel’s AI Foundry Dream Is Becoming Reality. What That Means for INTC Stock.Why Cathie Wood Just Massively Sold Archer Aviation StockWeakness May Be an Opportunity for CrowdStrike Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

The S&P 500 Index ($SPX) (SPY) today is down -0.28%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.38%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.28%.  June E-mini S&P futures (ESM26) are down -0.25%, and June E-mini Nasdaq futures (NQM26) are down -0.22%.

Stock indexes are sliding today, led by weakness in technology stocks, as investors rotate out of the sector, weighing on the broader market. Also, trucking companies are under pressure today after Amazon expanded its LTL freight offering to all destinations in the US, including third-party warehouses, distribution centers, and retail partners.  However, stock indexes recovered from their worst levels after US May consumer prices came in as expected, easing inflation concerns.

More News from Barchart

Dear Nvidia Stock Fans, Mark Your Calendars for June 11 Creating a 65% "Dividend" on RKLB Stock Using Options Oracle Earnings Could Reveal a Massive $100 Billion Spending Surge. Here Is Why You Should Still Buy ORCL Stock. Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now!

US May CPI rose +4.2% y/y, right on expectations and the fastest pace of increase in 3 years.  May core CPI rose +2.9% y/y, right on expectations, and the fastest pace of increase in 7 months.

US MBA mortgage applications rose +10.8% in the week ended June 5, with the purchase mortgage sub-index up +7.3% and the refinancing mortgage sub-index up +15.3%.  The average 30-year fixed rate mortgage rose +3 bp to 6.60% from 6.57% in the prior week.

WTI crude oil prices (CLN26) are up more than +1% today after the US and Iran exchanged strikes overnight.  The US said it had completed an operation that saw fighter jets strike Iranian air defenses, ground control stations, and radar sites near the Strait of Hormuz in retaliation for Iran shooting down a US Apache helicopter.  In response, Iran launched missiles at four US military targets and fired drones at the main US naval base in the Middle East, located in Bahrain, and struck Ali Al Salem air base in Kuwait.  Losses in crude prices accelerated today when President Trump said that Iran has taken too long to make a deal and that they will now have to "pay the price," fueling concerns that the US may escalate military attacks on Iran.

The markets are discounting a 0% chance of a +25 bp rate hike at the next FOMC meeting on June 16-17.

Overseas stock markets are lower today.  The Euro Stoxx 50 fell to a 2.5-week low and is down -0.34%. China's Shanghai Composite closed down -0.42%.  Japan's Nikkei Stock Average closed down -1.89%.

Story Continues

Interest Rates

September 10-year T-notes (ZNU6) today are down -2 ticks, and the 10-year T-note yield is up +0.6 bp to 4.523%.  T-notes are under pressure today after a +1% jump in WTI crude oil, which has raised inflation expectations.  Supply pressures are also weighing on T-note prices as the Treasury will auction $39 billion of 10-year T-notes later today.

Today's stock weakness has boosted some safe-haven demand for government debt securities and is limiting losses in T-notes.  Also, today's as-expected US May CPI report limited the downside in T-notes.

European government bond yields are moving higher today.  The 10-year German Bund yield climbed to a 2.5-week high of 3.088% and is up +2.7 bp to 3.070%.  The 10-year UK gilt yield is up +2.1 bp to 4.924%.

Swaps are discounting a 100% chance of a +25 bp ECB rate hike at its next policy meeting on Thursday.

US Stock Movers

The weakness in chipmakers and AI-infrastructure stocks is leading the broader market lower today.  Western Digital (WDC) and Broadcom (AVGO) are down more than -4%, and Seagate Technology Holdings Plc (STX) is down more than -3%.  Also, Micron Technology (MU) is down more than -2%, and Nvidia (NVDA), Microchip Technology (MCHP), NXP Semiconductors NV (NXPI), and Qualcomm (QCOM) are down more than -1%.

Trucking companies are under pressure today after Amazon expanded its LTL freight offering to all destinations in the US, including third-party warehouses, distribution centers, and retail partners.  ArcBest (ARCB) is down more than -7%, and Old Dominion Freight Line (ODFL) is down more than -6% to lead losers in the Nasdaq 100.  Also, Saia Inc (SAIA) and XPO Inc (XPO) are down more than -5%.  In addition, FedEx Freight Holding Co (FDXF), CH Robinson Worldwide (CHRW), and JB Hunt Transport Services (JBHT) are down more than -2%.

Airline stocks and cruise line operators are falling today, as WTI crude oil is up more than 1%, which boosts fuel costs and dampens profitability prospects.  United Airlines Holdings (UAL) and Alaska Air Group (ALK) are down more than -3%, and American Airlines Group (AAL), Delta Air Lines (DAL), and Royal Caribbean Cruises (RCL) are down more than -2%.  Also, Southwest Airlines (LUV), Carnival (CCL), and Norwegian Cruise Line Holdings (NCLH) are down more than -1%.

Energy producers and service providers are moving higher today, with WTI crude oil up more than +1%.  Devon Energy (DVN) is up more than +4%, and APA Corp (APA) is up more than +3%.  Also, ConocoPhillips (COP) is up more than +2%, and Marathon Petroleum (MPC), Phillips 66 (PSX), Chevron (CVX), Halliburton (HAL), and Valero Energy (VLO) are up more than +1%.

Dianthus Therapeutics (DNTH) is down more than -13% after peer developer Sanofi halted a late-stage trial of an experimental therapy for a rare autoimmune disorder, citing efficacy concerns.

Super Micro Computer (SMCI) is down more than -12% to lead losers in the S&P 500 after saying it plans $7 billion in equity and equity-linked financing transactions to fund component purchases.

Summit Therapeutics (SMMT) is down more than -3% after announcing it had commenced an underwritten public offering of $500 million of shares of its common stock.

Cracker Barrel Old Country Store (CBRL) is up more than +31% after raising its full-year revenue forecast to $3.27 billion to $3.30 billion from a previous estimate of $3.24 billion to $3.27 billion, stronger than the consensus of $3.25 billion.

Casey's General Stores (CASY) is up more than +14% to lead gainers in the S&P 500 after reporting Q4 revenue of $4.57 billion, above the consensus of $4.32 billion.

Illumina (ILMN) is up more than +2% after JPMorgan Chase upgraded the stock to overweight from neutral with a price target of $185.

Hinge Health (HNGE) is up more than +2% after raising its full-year revenue forecast to $818 million to $824 million from a previous estimate of $798 million to $804 million.

Earnings Reports(6/10/2026)

Chewy Inc (CHWY), Core & Main Inc (CNM), Oracle Corp (ORCL).

On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.

Top 5 Upgrades:

Barclays upgraded Oscar Health(OSCR) to Overweight from Equal Weight with a price target of $35, up from $30. The firm says that with "single-line exposure" to the individual Affordable Care Act market, Oscar offers the "most direct leverage to a potential multi-year multiple re-rating." Evercore ISI upgraded Devon Energy(DVN) to Outperform from In Line with a $54 price target. The better-than-expected mid-month update underscores not just improving capital efficiency, but also a "surprise, explicit comment on the portfolio review, with the key word being 'expeditiously'," the firm tells investors. JPMorgan upgraded Illumina (ILMN) to Overweight from Neutral with a price target of $185, up from $125. JPMorgan cites Illumina's customer "stickiness" and its favorable recent customer survey for the upgrade. UBS upgraded BorgWarner (BWA) to Buy from Neutral with a price target of $95, up from $61. The company is the best positioned auto supplier to benefit from non-auto opportunities, the firm tells investors in a research note. UBS upgraded Cava Group(CAVA) to Buy from Neutral with a price target of $90, up from $85. The company offers an attractive same-store-sales catalyst path with industry-leading unit growth, the firm tells investors in a research note.

Top 5 Downgrades:

RBC Capital downgraded Nike (NKE) to Sector Perform from Outperform with a price target of $50, down from $70. While the company's turnaround under CEO Elliott Hill is making progress, it is "slower and narrower" than expected, the firm tells investors in a research note. Guggenheim downgraded Nuvalent (NUVL) to Neutral from Buy with a price target of $124, down from $151, citing the proposed acquisition by GSK (GSK) for $124 per share in an all-cash transaction. UBS, TD Cowen, Barclays, and Truist also downgraded Nuvalent to Neutral-equivalent ratings. Berenberg downgraded Nutrien (NTR) to Hold from Buy with a price target of $65, up from $61. The company is likely to deliver another year of solid earnings, but the firm is concerned that consensus estimates "will continue to anchor on earnings levels that remain above mid-cycle." Wolfe Research downgraded Taylor Morrison(TMHC) to Peer Perform from Outperform without a price target following the announced acquisition by Berkshire Hathaway (BRK.A) for $72.50 per share. Truist downgraded Bill (BILL) to Hold from Buy with a price target of $35, down from $45. The firm finds it increasingly unlikely that a software-as-a-service company like Bill will be acquired given the uncertainty caused by AI.

Story Continues

Top 5 Initiations:

Bernstein initiated coverage of Honeywell (HON) with a Market Perform rating and $233 price target. While the firm thinks the spinoff of Honeywell Aerospace is "the right strategic move" for the company to re-focus on its automation core, it adds that the remaining business units are distinct types of automation without significant technology and customer overlap. Bernstein also started coverage of Rockwell Automation (ROK) and Carrier Global (CARR) with Market Perform ratings. Bernstein initiated coverage of Vertiv (VRT) with an Outperform rating and $416 price target. The firm says cites the company's "robust earnings power" for the Outperform rating. Bernstein also started coverage of Emerson (EMR), Trane (TT) and Johnson Controls (JCI) with Outperform ratings. Bernstein initiated coverage of 3M (MMM) with an Underperform rating and $131 price target. While the analyst thinks 3M leadership have done "a great job unlocking value with the transformation so far," the firm also worries that re-igniting the innovation engine will be "harder than expected" and adds that PFAS liabilities "refuse to disappear." Piper Sandler initiated coverage of SharkNinja (SN) with an Overweight rating and $150 price target. The company has an "impressive track record" of new innovations through both product launches and category expansions, the firm tells investors in a research note. Morgan Stanley initiated coverage of Blackstone Digital (BXDC) with an Equal Weight rating and $23 price target. The company offers exposure to a "large and growing" data center market, but its return profile is "highly dependent" on capital markets execution and acquisition discipline, the firm tells investors in a research note.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded fund launched on June 23, 2005.

Passively managed ETFs are becoming increasingly popular with institutional as well as retail investors due to their low cost, transparency, flexibility and tax efficiency. They are excellent vehicles for long term investors.

Sector ETFs are also funds of convenience, offering many ways to gain low risk and diversified exposure to a broad group of companies in particular sectors. Healthcare - Biotech is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 9, placing it in bottom 44%.

Index Details

The fund is sponsored by Invesco. It has amassed assets over $260.13 million, making it one of the average sized ETFs attempting to match the performance of the Healthcare - Biotech segment of the equity market. PBE seeks to match the performance of the Dynamic Biotechnology & Genome Intellidex Index before fees and expenses.

The Dynamic Biotech & Genome Intellidex Index seeks to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value.

Costs

When considering an ETF's total return, expense ratios are an important factor, and cheaper funds can significantly outperform their more expensive counterparts in the long term if all other factors remain equal.

Annual operating expenses for this ETF are 0.58%, making it on par with most peer products in the space.

It has a 12-month trailing dividend yield of 1.03%.

Sector Exposure and Top Holdings

While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. And, most ETFs are very transparent products that disclose their holdings on a daily basis.

This ETF has heaviest allocation in the Healthcare sector -- about 100% of the portfolio.

Looking at individual holdings, United Therapeutics Corp (UTHR) accounts for about 6.33% of total assets, followed by Illumina Inc (ILMN) and Regeneron Pharmaceuticals Inc (REGN).

The top 10 holdings account for about 48.13% of total assets under management.

Performance and Risk

Year-to-date, the Invesco Biotechnology & Genome ETF has added about 2.65% so far, and is up roughly 30.09% over the last 12 months (as of 06/10/2026). PBE has traded between $63.376 and $85.733 in this past 52-week period.

Story Continues

The ETF has a beta of 0.72 and standard deviation of 19.77% for the trailing three-year period, making it a high risk choice in the space. With about 33 holdings, it has more concentrated exposure than peers.

Alternatives

Invesco Biotechnology & Genome ETF carries a Zacks ETF Rank of 3 (Hold), which is based on expected asset class return, expense ratio, and momentum, among other factors. Thus, PBE is a good option for those seeking exposure to the Health Care ETFs area of the market. Investors might also want to consider some other ETF options in the space.

iShares Biotechnology ETF (IBB) tracks Nasdaq Biotechnology Index and the State Street SPDR S&P Biotech ETF (XBI) tracks S&P Biotechnology Select Industry Index. iShares Biotechnology ETF has $7.87 billion in assets, State Street SPDR S&P Biotech ETF has $8.01 billion. IBB has an expense ratio of 0.44%, and XBI charges 0.35%.

Bottom Line

To learn more about this product and other ETFs, screen for products that match your investment objectives and read articles on latest developments in the ETF investing universe, please visit Zacks ETF Center.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Invesco Biotechnology & Genome ETF (PBE): ETF Research Reports

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Der Aktienmarkt stieg am Donnerstag aufgrund eines gemeldeten Interim-Abkommens zwischen den USA und Iran auf neue Höhepunkte. Dell stieg über Nacht aufgrund der Earnings.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die wichtigsten Forschungsanfragen von Wall Street sind jetzt in einem einzigen Ort zusammengefasst. Hier sind die heutigen Forschungsanfragen, die Investoren wissen müssen, wie sie von The Fly zusammengestellt wurden.

Top 5 Aufwertungen: HSBC hat Cisco (CSCO) auf "Kaufen" heraufgestuft und ein Zielpreis von 137 $ festgelegt. Die Firma berichtete einen "modesten" Sieg im dritten Quartal, aber neue AI-Orders haben den Wachstumsdebatten wieder neu gestellt, da die Verwaltung für das Geschäftsjahr 2027 mindestens 6 Milliarden US-Dollar an AI-Einnahmen erwartet, was etwa 50 % jährliche Wachstum bedeutet. RBC Capital hat Texas Roadhouse (TXRH) auf "Überzeugend" heraufgestuft und ein Zielpreis von 210 $ festgelegt. Die Firma sieht das Potenzial für Rinderpreise, die "weniger ungünstig" für Texas Roadhouse sein werden, was zu einem Ausgleich der langfristigen Erwartungen an Margen führt. Raymond James hat Arista Networks (ANET) auf "Überzeugend" heraufgestuft und ein Zielpreis von 164 $ festgelegt. Die Firma erwartet, dass die Verkaufszahlen des Unternehmens in 2027 und darüber hinaus verbessert werden, da es neue Anwendungen wie Scale-Across expandiert und Marktanteile im Bereich AI-Hintergrund und Campus gewinnt. Stifel hat RXO Inc. (RXO) auf "Kaufen" heraufgestuft und ein Zielpreis von 22 $ festgelegt. Die Firma sieht eine günstigere Ausrichtung für den Rest des Jahres 2026, da das Unternehmen an der Kreuzung aus sich verbesserten Broker-Grundlagen und gesunden idiosynkratischen Leitern steht. Citi hat C.H. Robinson (CHRW) auf "Kaufen" heraufgestuft und ein unverändertes Zielpreis von 199 $ festgelegt, nachdem das Unternehmen bessere als erwartete Ergebnisse für Q1 veröffentlicht hatte, mit Margenverbesserungen.

Top 5 Herabstufungen: Barclays hat Doximity (DOCS) auf "Gleichgewicht" herabgestuft und ein Zielpreis von 20 $ festgelegt. Wachstum im digitalen Werbemarkt verlangsamt sich, während die Konkurrenz zunimmt, und daher erwartet Barclays eine "mangelhafte" Industriegewinnentwicklung, was den Aktien der Doximity begrenzt. Morgan Stanley hat Viking Holdings (VIK) auf "Gleichgewicht" herabgestuft mit einem Zielpreis von 86 $, nach oben korrigiert von 81 $. Die Firma hält Viking weiterhin für einen "Qualitätskomponisten", aber sagt, dass sein Bullenthese bereits abgelaufen ist. JPMorgan hat Allegion (ALLE) auf "Neutral" herabgestuft mit einem Zielpreis von 150 $, nach unten korrigiert von 170 $. Die Firma zitiert die Margen- und Bauheadwinds für die Herabstufung. JPMorgan hat A.O. Smith (AOS) auf "Underweight" herabgestuft mit einem Zielpreis von 60 $, nach unten korrigiert von 65 $. Die Firma ist vorsichtiger in Bezug auf Aktien, da das Unternehmen eine China- und Wohnungsunternehmen-Exposition hat. Evercore ISI hat Fermi (FRMI) auf "In Line" herabgestuft mit einem Zielpreis von 11 $, nach unten korrigiert von 20 $. Die Firma sagt, die Herabstufung sei "keine Ablehnung der langfristigen Knappheit des Projekts Matador" oder des breiteren Bedarfsthemas für Strom, sondern spiegelt eine geänderte Auswertungsstandard wider.

Top 5 Initiationen: Loop Capital hat die Deckung von Vertiv (VRT) mit einem Kaufrating und einem Zielpreis von 500 $ aufgenommen. Die Firma sagt, das Unternehmen habe ein "Flywheel" gerade als der "Industrie in den Vordergrund eines legitimen AI-Infrastruktur-Superzyklus tritt." Evercore ISI hat die Deckung von Biogen (BIIB) mit einem Überzeugend-Rating wieder aufgenommen. Biogens jüngste Aktualisierung "bringt eine Mischung aus Erkenntnissen über das Tau-Programm für Alzheimer-Behandlung" und obwohl der Haupteffektivitätspunkt nicht erreicht wurde, gibt es "wichtige Nuancen, die beachtet werden müssen", sagt die Firma an Investoren. Evercore ISI hat die Deckung von J.M. Smucker (SJM) mit einem Überzeugend-Rating aufgenommen. Smucker präsentiert "eine überzeugende Bewertung mit superiorem Wachstumspotenzial gegenüber Peers", sagt die Firma, und prognostiziert eine "robuste" erwartete EPS-Jahreswachstumsrate von etwa 9 % bis zum Jahr 2028, vor allem durch den Wiederaufleben des Kaffeesegments und betrieblicher Effizienzen. Wedbush hat die Deckung von Solventum (SOLV) mit einem Überzeugend-Rating aufgenommen. Die Firma glaubt, dass Aktien ein überzeugender, mehrfach-katalysierter Sonderfall darstellen, der asymmetrische Potenziale bietet. RBC Capital hat die Deckung von Illumina (ILMN) mit einem Überzeugend-Rating wieder aufgenommen. Die Firma sagt, ihr konstruktiver Standpunkt zum Stück sei durch wachsende klinische Impulse und abnehmende Konkurrenzbedenken untermauert.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Am Mittwoch kamen weitere schlechte Inflationsnachrichten herein. Der Producer Price Index stieg um 1,4 % im April. Die Produzentenpreise stiegen auch auf einem Jahresvergleich um 6 %, der höchste seit 2022. Viele Wall-Street-Economisten sagen jetzt, dass Zinssenkungen erst Sommer oder Herbst 2027 kommen könnten. Der Analyst, der NVIDIA 2010 richtig vorhergesagt hat, hat seine Top 10-Aktien benannt und Academy Sports & Outdoors war nicht dabei.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Der US-Präsident Donald Trump landete am Mittwoch in China für ein hochrangiges Treffen mit dem chinesischen Präsidenten Xi Jinping, begleitet von einer Roster von Unternehmensgrößen, die die Marktchancen hinter der Diplomatie unterstreichen.

NVDA-Aktien handeln bei Allzeithoch. Siehe den Chart und die Preisanalyse hier.

Trump hatte vor dem Trip auf Truth Social gesagt, er würde Xi bitten, "China zu öffnen", damit US-Unternehmensleiter "ihre Magie anwenden" können, fügte hinzu: "Ich werde das meine erste Bitte machen."